Cilo Cybin Holdings Limited

ZAC 90.00As of Sun 8 Nov 2026, 12:00 UTC
JSE:CCCHealthcare
Country South Africa
PE (Fwd) •••
TSR 2Y CAGR (47.44%)
Div yield —
ROE (512.05%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.47)
PE TTM —
TSR TTM (81.63%)
Mkt cap R 259.3M
ROIC (235.33%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ZAC 89
(0.88%)
150.76%
Hold 6|9|11|2|6
3Q26
4Q26
1Q27
2Q27
Earnings per shareR
1.57
1.58
1.63
1.63
15.93%
17.16%
20.36%
14.83%
RevenueR M
28.06
29.49
30.01
30.23
15.40%
15.20%
14.61%
13.05%
Peers (US$15.70M)
Cap (US$)
PE
7.464M
68.07x
2.268M
0.277x
Capital
TTM
5Y
10Y
Leveragex
1.013
0.406
0.398
EBIT/Intx
2.449
1.223
1.666
Own earn%
(137.19)
45.36
41.29
Sh yield%
28.00
43.82
44.34
Owners
Insiders/Inst%
3.46
89.81
Short interest%
0.55
SBC / revenue%
3.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
3–8
$1 testx
—
Incr. ROIC%
2